Publications by authors named "Vivek Naranbhai"

58Publications

Host genetic variation and HIV disease: from mapping to mechanism.

Immunogenetics 2017 08 10;69(8-9):489-498. Epub 2017 Jul 10.

Cancer and Inflammation Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00251-017-1000-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537324PMC
August 2017

Chemokines additional to IFN-γ can be used to differentiate among Mycobacterium tuberculosis infection possibilities and provide evidence of an early clearance phenotype.

Tuberculosis (Edinb) 2017 07 18;105:28-34. Epub 2017 Apr 18.

Department of Microbiology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand; Research and Diagnostic Center for Emerging Infectious Diseases (RCEID), Khon Kaen University, Khon Kaen, Thailand. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S14729792173005
Publisher Site
http://dx.doi.org/10.1016/j.tube.2017.04.005DOI Listing
July 2017

HLA-C Level Is Regulated by a Polymorphic Oct1 Binding Site in the HLA-C Promoter Region.

Am J Hum Genet 2016 Dec 3;99(6):1353-1358. Epub 2016 Nov 3.

Cancer and Inflammation Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajhg.2016.09.023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142108PMC
December 2016

The Role of Host Genetics (and Genomics) in Tuberculosis.

Authors:
Vivek Naranbhai

Microbiol Spectr 2016 10;4(5)

Wellcome Trust Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, Oxfordshire OX37BN, United Kingdom; Centre for the AIDS Programme of Research in South Africa, University of KwaZulu Natal, Durban, South Africa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/microbiolspec.TBTB2-0011-2016DOI Listing
October 2016

Cytokine Profiles during Invasive Nontyphoidal Salmonella Disease Predict Outcome in African Children.

Clin Vaccine Immunol 2016 07 5;23(7):601-9. Epub 2016 Jul 5.

School of Immunity and Infection, College of Medicine and Dental Sciences, University of Birmingham, Birmingham, United Kingdom Malawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, University of Malawi, Blantyre, Malawi Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/CVI.00128-16DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933780PMC
July 2016

Genomic modulators of gene expression in human neutrophils.

Nat Commun 2015 Jul 7;6:7545. Epub 2015 Jul 7.

Wellcome Trust Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms8545DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4507005PMC
July 2015

Genital inflammation and the risk of HIV acquisition in women.

Clin Infect Dis 2015 Jul 21;61(2):260-9. Epub 2015 Apr 21.

Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/civ298DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565995PMC
July 2015

The association between the ratio of monocytes: lymphocytes and risk of tuberculosis among HIV-infected postpartum women.

J Acquir Immune Defic Syndr 2014 Dec;67(5):573-5

*Wellcome Trust Centre for Human Genetics Jenner Institute-Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom; †Department of Obstetrics and Gynaecology, Center for the AIDS Programme of Research in South Africa, and Women's Health and HIV Research Unit, University of KwaZulu Natal, Durban, South Africa; ‡University of Zimbabwe College of Medicine Harare, Harare, Zimbabwe; §Department of Obstetrics and Gynaecology, Makerere University-Johns Hopkins University Research Collaboration, Kampala, Uganda; ‖Department of Paediatrics, Makerere University, Kampala, Uganda; ¶Department of Paediatrics and Child Health, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania; #FHI 360, Research Triangle Park, School of Medicine, Durham, NC; **School of Medicine, Johns Hopkins University, Baltimore, MD; and ††Maternal Adolescent and Child Health, University of the Witwatersrand, Johannesburg, South Africa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000000353DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229408PMC
December 2014

HIV disease progression in seroconvertors from the CAPRISA 004 tenofovir gel pre-exposure prophylaxis trial.

J Acquir Immune Defic Syndr 2015 Jan;68(1):55-61

*Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa; †Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom; ‡Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom; §Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa; ‖National Health Laboratory Service, South Africa; ¶AIDS Virus Research Unit, National Institute for Communicable Diseases, Johannesburg, South Africa; and #Department of Epidemiology, Columbia University, New York, NY USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000000367DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4262710PMC
January 2015

TRIM5α and TRIM22 are differentially regulated according to HIV-1 infection phase and compartment.

J Virol 2014 Apr 29;88(8):4291-303. Epub 2014 Jan 29.

KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH), Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JVI.03603-13DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3993776PMC
April 2014

Compartmentalization of innate immune responses in the central nervous system during cryptococcal meningitis/HIV coinfection.

AIDS 2014 Mar;28(5):657-66

aCentre for the AIDS Programme of Research in South Africa bHIV Pathogenesis Programme, Nelson R Mandela School of Medicine, University of KwaZulu Natal, Durban, South Africa cNuffield Department of Medicine, University of Oxford, Oxford, UK dDepartment of Infectious Diseases, Monash University and Alfred Hospital eCentre for Biomedical Research, Burnet Institute, Melbourne fSchool of Pathology and Laboratory Medicine, University of Western Australia, Perth, Australia gDepartment of Infectious Diseases, Nelson R Mandela School of Medicine hKwaZulu-Natal Research Institute for Tuberculosis and HIV(K-RITH), University of KwaZulu Natal, Durban, South Africa iMax Planck Institute for Infection Biology, Berlin, Germany jMedgar Evers College (City University of New York), Brooklyn, New York, USA. *Vivek Naranbhai and Christina C. Chang contributed equally to the writing of the article.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/aidsonline/2014/03130/Compartme
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/QAD.0000000000000200DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4077985PMC
March 2014

A systematic review of definitions of extreme phenotypes of HIV control and progression.

AIDS 2014 Jan;28(2):149-62

aWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton bStrangeways Research Laboratory, Department of Public Health and Primary Care, University of Cambridge, Wort's Causeway, Cambridge cMedical Research Council, Clinical Trials Unit, Aviation House, London, UK dCentre for the AIDS Programme of Research in South Africa (CAPRISA), Doris Duke Medical Research Institute, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa eWellcome Trust Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford fImperial College Healthcare NHS Trust, London gCambridge University Hospitals NHS Foundation Trust, Department of Infectious Diseases, Addenbrooke's Hospital, Cambridge hKing's College London, Weston Education Centre iDivision of Infection and Immunity, University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000000049DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3882304PMC
January 2014

No evidence for selection of HIV-1 with enhanced gag-protease or Nef function among breakthrough infections in the CAPRISA 004 tenofovir microbicide trial.

PLoS One 2013 28;8(8):e71758. Epub 2013 Aug 28.

HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa ; KwaZulu-Natal Research Institute for Tuberculosis and HIV, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa ; Institute of Infectious Disease and Molecular Medicine, and the Division of Medical Virology, University of Cape Town and National Health Laboratory Services, Cape Town, South Africa ; Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada ; British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0071758PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3756015PMC
May 2014

Clinical and mycological predictors of cryptococcosis-associated immune reconstitution inflammatory syndrome.

AIDS 2013 Aug;27(13):2089-99

aDepartment of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Australia bDepartment of Infectious Diseases, King Edward VIII Hospital cHIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa dCentre for Virology, Burnet Institute, Melbourne, Australia eDepartment of Medical Microbiology, National Health Laboratory Services, Inkosi Albert Luthuli Central Hospital Academic Complex fDepartment of Microbiology and Infection Control, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa gCentre for Population Health, Burnet Institute, Melbourne, Australia hCentre for the AIDS Programme of Research in South Africa, Doris Duke Medical Research Institute, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa iSchool of Pathology and Laboratory Medicine, University of Western Australia jDepartment of Clinical Immunology, Royal Perth Hospital and PathWest Laboratory Medicine, Perth, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0b013e3283614a8dDOI Listing
August 2013

Changes in Natural Killer cell activation and function during primary HIV-1 Infection.

PLoS One 2013 9;8(1):e53251. Epub 2013 Jan 9.

CAPRISA - Centre for the AIDS Programme of Research in South Africa, Doris Duke Medical Research Institute, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0053251PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541400PMC
July 2013

Preservation HIV-1-specific IFNγ+ CD4+ T-cell responses in breakthrough infections after exposure to tenofovir gel in the CAPRISA 004 microbicide trial.

J Acquir Immune Defic Syndr 2012 Jun;60(2):124-7

HIV Pathogenesis Program, Doris Duke Medical Research Institute and KwaZulu-Natal Research Institute for TB and HIV (KRITH), Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0b013e31824f53a9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3381429PMC
June 2012

Impact of blood processing variations on natural killer cell frequency, activation, chemokine receptor expression and function.

J Immunol Methods 2011 Mar 19;366(1-2):28-35. Epub 2011 Jan 19.

HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R Mandela School of Medicine, University of KwaZulu Natal, Durban, South Africa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jim.2011.01.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3051017PMC
March 2011

Interventions to modify sexual risk behaviours for preventing HIV in homeless youth.

Cochrane Database Syst Rev 2011 Jan 19(1):CD007501. Epub 2011 Jan 19.

Centre for the AIDS Programme of Research in South Africa, Doris Duke Medical Research Institute, Nelson R Mandela School of Medicine, University of KwaZulu Natal, Congella, Durban, KwaZuluNatal, South Africa, 4001.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/14651858.CD007501.pub2
Publisher Site
http://dx.doi.org/10.1002/14651858.CD007501.pub2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624078PMC
January 2011